Using the Calm app to help hematological cancer patients with sleep problems
Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients
This study is looking at whether the Calm meditation app can help people with chronic blood cancers sleep better, offering an easy and at-home way to tackle sleep problems without medication.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Science Center NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11074535 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of the Calm meditation app in improving sleep disturbances among patients with chronic hematological cancers. It aims to provide a non-pharmacologic intervention that is easily accessible and can be used at home, addressing the common issue of sleep disturbances that these patients face due to their condition. Participants will engage with the app over a specified period, and their sleep patterns will be monitored using actigraphy to assess improvements. The study seeks to determine if this digital approach can serve as a viable alternative to traditional therapies like cognitive behavioral therapy for insomnia.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with chronic hematological cancers who experience sleep disturbances.
Not a fit: Patients with acute hematological cancers or those who do not experience sleep disturbances may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer hematological cancer patients a convenient and effective tool to improve their sleep quality without the side effects associated with medications.
How similar studies have performed: Previous research has shown that meditation can effectively improve sleep quality in various patient populations, suggesting potential success for this approach in hematological cancer patients.
Where this research is happening
San Antonio, United States
- University of Texas Hlth Science Center — San Antonio, United States (Active)
Researchers
- Principal investigator: Huberty, Jennifer Lynne — University of Texas Hlth Science Center
- Study coordinator: Huberty, Jennifer Lynne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.